Gain Therapeutics
GANX • NASDAQ
Gain Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gene Mack, with a market cap of $70.4M.
CEOGene Mack
Next Earnings
Upcoming earnings announcement for Gain Therapeutics
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.14
Earnings History
Past 12 earnings reports for Gain Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.11Est: -$0.14 | +21.4% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.15Est: -$0.15 | 0.0% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.19Est: -$0.17 | -11.8% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.16Est: -$0.17 | +5.9% | —Est: $33.3K | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.11Est: -$0.17 | +35.3% | -Est: $30.0K | -100.0% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.17Est: -$0.21 | +19.0% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.42Est: -$0.20 | -110.0% | -Est: $400.0K | -100.0% | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.22Est: -$0.29 | +24.1% | -Est: $30.0K | -100.0% | 10-Q |
| Mar 26, 2024 | Q4 2023 | -$0.29Est: -$0.32 | +9.4% | -Est: $320.0K | -100.0% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.37Est: -$0.45 | +17.8% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.62Est: -$0.31 | -100.0% | -Est: $1.0M | -100.0% | 10-Q |
| May 12, 2023 | Q1 2023 | -$0.43 | — | $55.2K | — | — |